ANI Pharmaceuticals has expanded its branded product portfolio by striking a deal to acquire several dermatology products from Sandoz in the US. The firm said the “accretive transaction” was “in line with the growth strategy laid out for the branded products business.”
ANI Picks Up US Dermatology Brands From Sandoz
Transaction Follows Soon After Deal For Novitium Pharma
ANI Pharmaceuticals has added to its branded portfolio by acquiring several dermatology brands from Sandoz in the US.
